Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Journal
Age
Showing 1 to 12 of 1809 entries
Sorted by: Best Match Show Resources per page
Treatment of deep vein thrombosis (DVT) with low molecular weight heparins (LMWH).

Advances in experimental medicine and biology

Samama MM.
PMID: 1332441
Adv Exp Med Biol. 1992;313:275-81. doi: 10.1007/978-1-4899-2444-5_27.

No abstract available.

Comparison of low molecular weight heparin to standard heparin in hemodialysis/hemofiltration.

Kidney international

Schrader J, Stibbe W, Armstrong VW, Kandt M, Muche R, Köstering H, Seidel D, Scheler F.
PMID: 2838681
Kidney Int. 1988 Apr;33(4):890-6. doi: 10.1038/ki.1988.81.
Free Article

Low molecular weight (LMW) heparin has been compared to standard unfractionated (UF) heparin in hemodialysis/hemofiltration in a 12 month, randomized study. Seventy patients with end-stage chronic renal failure starting dialysis treatment were randomly assigned to one of two groups...

Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis.

Lancet (London, England)

Prandoni P, Lensing AW, Büller HR, Carta M, Cogo A, Vigo M, Casara D, Ruol A, ten Cate JW.
PMID: 1346817
Lancet. 1992 Feb 22;339(8791):441-5. doi: 10.1016/0140-6736(92)91054-c.

In view of the potential of low-molecular-weight heparins (LMWH) to simplify initial therapy and allow outpatient treatment of proximal deep-vein thrombosis, we undertook a randomised comparison of fixed-dose subcutaneous LMWH with adjusted-dose intravenous standard heparin in the initial treatment...

A randomised trial of subcutaneous low molecular weight heparin (CY 216) compared with intravenous unfractionated heparin in the treatment of deep vein thrombosis. A collaborative European multicentre study.

Thrombosis and haemostasis

[No authors listed]
PMID: 1646490
Thromb Haemost. 1991 Mar 04;65(3):251-6.

The standard treatment of deep vein thrombosis is given by continuous intravenous infusion of unfractionated heparin. This entails hospitalisation, nursing care, immobility and repeated laboratory tests (e.g. activated partial thromboplastin time [APTT], platelet count). In addition approximately 10% of...

The relationship between ex vivo anti-factor Xa levels and efficacy/safety of low molecular weight heparin.

British journal of clinical practice. Supplement

Turpie AG.
PMID: 2554949
Br J Clin Pract Suppl. 1989 Jan;65:18-23; discussion 23-5.

No abstract available.

Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients.

Thrombosis research

Harenberg J, Kallenbach B, Martin U, Dempfle CE, Zimmermann R, Kübler W, Heene DL.
PMID: 2173168
Thromb Res. 1990 Aug 01;59(3):639-50. doi: 10.1016/0049-3848(90)90422-9.

166 patients aged 40-80 years were included in a controlled, randomized, double-blind study to determine the efficacy and safety of a single daily injection of a low molecular weight (LMW) heparin for prevention of deep-vein thrombosis compared to low...

Long term anticoagulation with low molecular weight heparin in outpatients with side effects on oral anticoagulants.

Nouvelle revue francaise d'hematologie

Harenberg J, Leber G, Dempfle CE, Heene DL, Zimmermann R, Kübler W.
PMID: 2555770
Nouv Rev Fr Hematol. 1989;31(5):363-9.

A total of 70 outpatients with previous severe haemorrhages and other side effects on conventional oral anticoagulants given for prophylaxis of tromboembolism, were treated with low molecular weight (LMW) heparin fraction Kabi 2165. Anticoagulation was necessary in all patients...

A prospective randomized trial of low molecular weight heparin-DHE and conventional heparin-DHE (with acenocoumarol) in patients undergoing gynaecological surgery.

Archives of gynecology and obstetrics

Steiner RA, Keller K, Lüscher T, Schreiner WE.
PMID: 2544152
Arch Gynecol Obstet. 1989;244(3):141-50. doi: 10.1007/BF00931291.

The antithromboembolic efficacy of once a day low molecular weight heparin in fixed combination with dihydroergotamine (LMWH-DHE) was compared with conventional heparin-DHE in combination with Acenocoumarol (heparin-DHE/A) in 191 patients undergoing gynaecological surgery. LMWH-DHE proved equally effective in preventing...

[Massive pulmonary embolism disclosing thrombocytopenia induced by low molecular weight heparin. Therapeutic success of prostacyclin].

Annales de cardiologie et d'angeiologie

Metz D, N'Guyen P, Chapoutot L, Graciet J, Taupin JM, Grentzinger A, Elaerts J, Bajolet A.
PMID: 1723582
Ann Cardiol Angeiol (Paris). 1991 Dec;40(10):619-21.

The authors report a case of massive pulmonary embolism revealing thrombocytopenia induced by a low molecular weight heparin (LMWH) initially proposed for the treatment of superficial phlebitis. The diagnosis was confirmed by in vitro aggregation tests and a fall...

[Prevention of vascular thromboses after renal transplantation using low molecular weight heparin].

Annales de pediatrie

Broyer M, Gagnadoux MF, Sierro A, Fischer AM, Révillon Y, Jan D, Beurton D, Niaudet P.
PMID: 1656836
Ann Pediatr (Paris). 1991 Jun;38(6):397-9.

Vascular thrombosis is one of the main causes of early transplant failure in pediatric patients. This paper reports the results of an open trial of the low molecular weight heparin (Enoxaparine) used to prevent renal graft thrombosis in pediatric...

Subcutaneous low molecular weight heparin versus subcutaneous unfractionated heparin in the treatment of deep vein thrombosis: a Polish multicenter trial.

Thrombosis and haemostasis

Lopaciuk S, Meissner AJ, Filipecki S, Zawilska K, Sowier J, Ciesielski L, Bielawiec M, Glowinski S, Czestochowska E.
PMID: 1325076
Thromb Haemost. 1992 Jul 06;68(1):14-8.

In a prospective multicenter trial, 149 consecutive patients with phlebographically proven proximal and/or distal deep vein thrombosis of the leg were randomly allocated to receive subcutaneously for 10 days either low molecular weight heparin CY 216 (Fraxiparine) in a...

[Thrombocytopenia induced by low molecular weight heparin].

Annales francaises d'anesthesie et de reanimation

Chin SP, Alvado G, Lemoine P.
PMID: 1335704
Ann Fr Anesth Reanim. 1992;11(5):587-91. doi: 10.1016/s0750-7658(05)80765-8.

Two cases of thrombocytopenia due to a low molecular weight heparin (Fraxiparine) are reported. The first case was a 35-year-old alcoholic man with acute mild pancreatitis. After having been treated with Fraxiparine for 12 days to prevent venous thrombosis,...

Showing 1 to 12 of 1809 entries